Universal screening or a universal risk assessment combined with risk-based screening for multidrug-resistant microorganisms upon admission: Comparing strategies.
Adriënne S van der SchoorJuliëtte A SeverinCorné H W KlaassenJohannes P C van den AkkerMarco J BrunoJohanna M HendriksMargreet C VosAnne F Voor In 't HoltPublished in: PloS one (2023)
Our results show that in our low endemic setting, a universal screening strategy identified significantly more MDRO carriers than the currently implemented universal risk-assessment. When implementing a universal risk-assessment, risk factors should be carefully selected to be able to identify ESBL-E carriers. While the universal screening identified more MDRO carriers, further research is needed to determine the cost-effectiveness of this strategy.